Support for HPV16L1/RG1 chimeric virus-like particle vaccine clinical development tasks 1 & 2 PP: 9/25/2015 to 9/24/2018

Ended Awarded Last action

Contract number
HHSN26100002
Awardee
Awarding agency
Obligated
$1,931,792

Award facts

Opportunity
  • N01CN4500045 Solicitation number
Contract value 100% obligated
$1,931,792.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Champaign, IL 61820, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00014 -$4,167
Other Administrative Action P00013 $0
Supplemental Agreement for work within scope P00012 $0
Other Administrative Action P00011 $0
Change Order P00010 · Preclinical prevent cancer program: toxicology and pharmacology studies; support for vaccine clinical development tasks $28,823
Other Administrative Action P00009 $4,167
Other Administrative Action P00008 $0
Other Administrative Action 7 $0
Other Administrative Action 6 $0
Change Order 5 $252,488
Exercise an Option 4 $325,398
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $1,325,083
Show all 15

About this award

Written by GovTribe AI ·

This federal contract award was made by the National Cancer Institute (NCI), a civilian agency, to the University of Illinois. The contract, valued at $1,931,792.00, supports the clinical development of an HPV16L1/RG1 chimeric virus-like particle vaccine under the NCI's PRECLINICAL PREVENT TOXICOLOGY AND PHARMACOLOGY major program. The contract has a period of performance from September 25, 2015 to December 31, 2021 and does not have a set-aside designation. The University of Illinois is the prime contractor on this Firm Fixed Price Delivery Order contract, which is a task order issued under the PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) indefinite delivery/indefinite quantity (IDIQ) contract.

Quick answers

Who was awarded contract HHSN26100002?

HHSN26100002 was awarded to University Of Illinois by National Cancer Institute (National Institutes of Health) on September 25, 2015.

How much is contract HHSN26100002 worth?

The government has obligated $1,931,792 on HHSN26100002.

Is contract HHSN26100002 an order under another contract?

Yes. HHSN26100002 is a delivery order under HHSN261201500026I, an indefinite delivery contract, on PREVENT Toxicology and Pharmacology Testing (PREVENT TOX).

Was contract HHSN26100002 competed?

The extent of competition for HHSN26100002 was full and open competition. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login